Purdue Pharma pursues patent infringement suit involving OxyContin(R) against generic drug maker Teva
Clients Purdue Pharma L.P.
Jones Day represents Purdue Pharma L.P., The P.F. Laboratories, Inc., and Purdue Pharmaceuticals L.P. in a Hatch-Waxman Act patent infringement litigation matter relating to Teva Pharmaceuticals USA, Inc.'s attempt to market a generic version of Purdue's controlled-release OxyContin(R) pain relief medication.
Purdue Pharma L.P. et al. v. Teva Pharm. USA, Inc., 1:14-cv-02357 (S.D.N.Y.)